Jacobs Levy Equity Management, Inc Axogen, Inc. Transaction History
Jacobs Levy Equity Management, Inc
- $24.7 Billion
- Q3 2024
A detailed history of Jacobs Levy Equity Management, Inc transactions in Axogen, Inc. stock. As of the latest transaction made, Jacobs Levy Equity Management, Inc holds 58,930 shares of AXGN stock, worth $734,857. This represents 0.0% of its overall portfolio holdings.
Number of Shares
58,930
Previous 85,107
30.76%
Holding current value
$734,857
Previous $616,000
34.09%
% of portfolio
0.0%
Previous 0.0%
Shares
19 transactions
Others Institutions Holding AXGN
# of Institutions
163Shares Held
36.6MCall Options Held
230KPut Options Held
400-
First Light Asset Management, LLC Edina, MN4.09MShares$51 Million5.0% of portfolio
-
Black Rock Inc. New York, NY3.25MShares$40.5 Million0.0% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT3.01MShares$37.5 Million3.58% of portfolio
-
Morgan Stanley New York, NY2.9MShares$36.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.43MShares$30.2 Million0.0% of portfolio
About Axogen, Inc.
- Ticker AXGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 42,283,700
- Market Cap $527M
- Description
- AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...